75. クッシング病 Cushing disease Clinical trials / Disease details

臨床試験数 : 205 / 薬物数 : 176 - (DrugBank : 45) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 127

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05347979 (ClinicalTrials.gov)	May 25, 2022	18/4/2022	Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate DabigatranE ...	An Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Ph ...	Cushing Syndrome;Neoplasms	Drug: Dabigatran Etexilate;Drug: Relacorilant	Corcept Therapeutics	NULL	Completed	18 Years	55 Years	All	30	Phase 1	United States

First Previous1Next Last